Literature DB >> 14586168

Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux.

Adiya Bakhiya1, Andrew Bahn, Gerhard Burckhardt, Natascha Wolff.   

Abstract

BACKGROUND/AIMS: Renal secretion of organic anions is critically dependent on their basolateral uptake against the electrochemical gradient. Due to their localization, two transporters are likely involved, namely OAT1 and OAT3. While OAT1 as an exchanger clearly operates in the secretory direction, OAT3 in its previously supposed mode as a uniporter should move anionic substrates from cell to blood. It would thus dissipate gradients established by OAT1 of common OAT1/OAT3 substrates. In the present study we therefore reinvestigated the driving forces of human OAT3.
METHODS: The human OAT3 obtained Xenopus laevis oocyte expression system, hOAT3-mediated transport of estrone sulfate (ES) and dicarboxylates was assayed for cis-inhibition and/or trans-stimulation in both the uptake and efflux direction.
RESULTS: hOAT3-mediated efflux of glutarate (GA), can be significantly trans-stimulated by a variety of ions with high cis-inhibitory potency, including GA (282%), alpha-ketoglutarate (476%), p-aminohippurate (179%), and, most notably, urate (167%). Urate cis-inhibited ES uptake with an IC(50) close to normal serum urate concentrations.
CONCLUSION: These data indicate that OAT3 does not represent a uniporter but operates as an organic ion%dicarboxylate exchanger similar to OAT1, and may mediate renal urate secretion. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586168     DOI: 10.1159/000074539

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  43 in total

1.  Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS).

Authors:  Matthias Rödiger; Xiaohong Zhang; Bernhard Ugele; Nikolaus Gersdorff; Stephen H Wright; Gerhard Burckhardt; Andrew Bahn
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

Review 2.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

4.  Renal elimination of organic anions in cholestasis.

Authors:  Adriana Monica Torres
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 5.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

6.  Implications of the alternating access model for organic anion transporter kinetics.

Authors:  Satish A Eraly
Journal:  J Membr Biol       Date:  2008-11-18       Impact factor: 1.843

Review 7.  The systems biology of uric acid transporters: the role of remote sensing and signaling.

Authors:  Sanjay K Nigam; Vibha Bhatnagar
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

Review 8.  Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis.

Authors:  Anabel Brandoni; María Herminia Hazelhoff; Romina Paula Bulacio; Adriana Mónica Torres
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

9.  Multiple organic anion transporters contribute to net renal excretion of uric acid.

Authors:  Satish A Eraly; Volker Vallon; Timo Rieg; Jon A Gangoiti; William R Wikoff; Gary Siuzdak; Bruce A Barshop; Sanjay K Nigam
Journal:  Physiol Genomics       Date:  2008-02-12       Impact factor: 3.107

10.  What lies behind serum urate concentration? Insights from genetic and genomic studies.

Authors:  Kimiyoshi Ichida
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.